Cannabis Short Interest Takes a Dive
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased, and in one stock incredibly.
All Work
Chris Lange
Major Biotechs See More Targeted Short Sellers
The May 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks was mixed.
Short Sellers Can’t Make Up Their Minds on Semiconductors
The May 15 short interest data have been compared with the previous report. Short interest moves in these selected semiconductor stocks were mixed.
Domestic Reopening Likely to Send Disney Stock Higher
A sustainable rally looks like the theme for Disney stock as parks and properties reopen.
Is It Finally Time for Shopify Stock to Pull Back?
Shopify’s stock has had an incredible run and might still have more upside as the company recently shored up its balance sheet with a secondary stock offering.
Is Luckin Coffee in the Middle of a Dead Cat Bounce?
Luckin Coffee shares jumped again on Wednesday, after posting an incredible gain on Tuesday. Is there anything behind this move, or is this just a dead cat bounce?
Will Dollar General or Dollar Tree Have the Better Q1 Report?
Both Dollar General and Dollar Tree are scheduled to announce their most recent quarterly reports on Thursday morning. Which discount retailer will have a better report?
Why Mersana’s Cancer Study Is Huge
Mersana Therapeutics shares jumped on Wednesday after the company reported interim results from its early-stage cancer study.
Chesapeake Energy Stock’s Summer of Doom and Gloom
The reopening of the U.S. economy may not save Chesapeake Energy as oil prices remain weak and the company’s finances look bleak.
Gates Foundation Likely to Be Rewarded for Apple Stock Buy
The Gates Foundation recently joined Warren Buffett and lots of other investors as holders of Apple stock.
Diffusion Pharma’s COVID-19 Treatment Takes a Big Step Forward With the FDA
Diffusion Pharmaceuticals shares pushed higher to start the week after it announced a critical update from the FDA concerning its potential treatment for COVID-19 patients displaying severe respiratory symptoms and low oxygen levels.
Meet Merck’s Newest Collaborations in the Fight Against COVID-19
Merck shares jumped on Tuesday after the company announced that it has made deals to develop drugs in the fight against COVID-19.
Why the Novavax Vaccine Update Is Huge
Novavax shares jumped to start off the week after an update from its COVID-19 vaccine trial. This news adds to investor optimism and is helping to lift the broad markets in general.
Is AutoZone Poised for New Highs After Earnings?
AutoZone reported better than expected fiscal third-quarter financial results before the markets opened on Tuesday.
Costco, Dollar General, Dollar Tree, HP, Salesforce and Others Reporting This Week
24/7 Wall St. takes a look at Costco, Salesforce and some of the other key companies reporting quarterly results in this truncated trading week.
Will E-Commerce Shops Deliver a Boost for Facebook Stock?
Facebook’s Shops feature will leverage the social network’s huge user base and create new competition for Amazon.
Amarin Stock’s Potential Unhampered by Generic Approval
Amarin will trial Vascepa as a COVID-19 treatment and that could more than offset investor concerns about patent litigation.
Why This Rheumatoid Arthritis Study Is Huge for Navidea Biopharma
Navidea Biopharmaceuticals shares more than doubled to close out the week after the company provided an update from its midstage study in patients with active rheumatoid arthritis.
How XpresSpa Is Capitalizing on the Fight Against COVID-19
XpresSpa shares jumped as the week wound down after the company gave an update on its COVID-19 efforts on Friday.
Is Alibaba’s Bottom Line Beat Enough for Investors?
Alibaba released better than expected fiscal fourth-quarter financial results before the markets opened on Friday.